GEORGE KING BIO-MEDICAL, INC.

George King Bio-Medical, Inc. is a specialized manufacturer of diagnostic coagulation and thrombosis products, serving clinical hematology laboratories. The company produces control plasma products used for quality assurance and calibration in coagulation testing, including pooled normal plasma, heparin control plasma, and factor assay control plasmas (FACT, B-FACT, A-FACT). Their product portfolio encompasses coagulation control plasmas, factor-deficient plasmas, specialty control plasmas, and related diagnostic kits. The company maintains a certified quality management system and emphasizes reliable customer support and shipping. George King Bio-Medical serves hospital and clinical laboratory markets where coagulation monitoring and hemostasis diagnostics are critical for patient care. The company was recently acquired by Precision BioLogic Inc. (October 2025), a leading hemostasis diagnostics developer, expanding its distribution and product capabilities. Operations are based in Kansas with toll-free and international customer support channels.